Search Results

You searched for : DSMB  

	New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms The latest studies claim 76% efficacy, DSMB still has doubts... Mar 25
	Dr Reddy's granted approval for 3rd stage Human Trials from DCGI : Russian Sputnik V vaccine Sputnik V phase 3 trials cleared by the government... Jan 16
	RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ... Jan 02
	RedHill's phase 2/3 COVID-19 study of opaganib passes second DSMB with unanimous recommendation to continue Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ... Dec 22
	The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ... Dec 17
	Moderna announces amendment to supply agreement of COVID vaccine with the ministry of health of Israel This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel... Dec 05
	RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
	Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines... Nov 19
	BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator BioAegis Therapeutics announced that it has expanded its clinical trial in severe COVID-19 to additional sites in Europe.... Nov 16
	Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), ... Nov 10
	Johnson & Johnson Temporarily Pauses All Dosing in their Janssen COVID-19 Vaccine Candidate Clinical Trials Johnson & Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, ... Oct 13
	Fast track designation from FDA received by Plus Therapeutics Plus Therapeutics receives fast track designation from FDA for its novel glioblastoma treatment ... Sep 16
	AstraZeneca to start Phase 3 trials of COVID vaccine in United States AstraZeneca closer to COVID vaccine as 3rd phase trial starts... Sep 01
	Phase 2 human trials for Bharat Biotech vaccine to begin in September A brief roundup of all the vaccines under development ... Aug 14
	Zydus Cadila announces completion of dosing in Phase I clinical trial of ZyCoV-D The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies, it also able to elicit high level of ... Aug 05
	DCGI nod to Serum Institute of India to conduct phase 2 & 3 trials Serum Institute allowed to carry on final trials of the Oxford University vaccine... Aug 03
	WHO discontinues HCQ and Lopinavir/Ritonavir treatment for Coronavirus Finally WHO discontinues HCQ and Lopinavir/Ritonavir ... Jul 06
	Clinical testing of remdesivir with baricitinib for COVID-19 begins Investigators currently anticipate enrolling more than 1,000 participants... May 14
18 Matching result(s) found!

Trending Now
	The Value of Risk Communication in Public HealthOctober 08, 2026
	What Makes a Reliable Health Screening Programme?October 08, 2026
	How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
	Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
	AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
	AI and Patient Consent in India: Who Is Responsible?October 06, 2026
	Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
	Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
	Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
	Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
	Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
	Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
	Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
	Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
	Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
	The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026